Aspirin Therapy on Prophylactic Anticoagulation for Patients Hospitalized With COVID‐19: A Propensity Score‐Matched Cohort Analysis of the HOPE‐COVID‐19 Registry
et al., Journal of the American Heart Association,
HOPE-COVID-19 PSM retrospective 7,824 patients, comparing prophylactic anticoagulation with and without additional treatment with aspirin in hospitalized patients, showing lower mortality with aspirin treatment.
risk of death, 38.0% lower, HR 0.62, p = 0.02, treatment 360, control 2,949.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
Santoro et al., 6/22/2022, retrospective, propensity score matching, multivariable, multiple countries, multiple regions, peer-reviewed, 31 authors, study period 16 January, 2020 - 30 May, 2020.